| Autor: |
Joseph Tsai, Balamurugan Vellayappan, Vyshak Venur, Tresa McGranahan, Heidi Gray, Renata R. Urban, Yolanda D. Tseng, Joshua Palmer, Matthew Foote, Nina A. Mayr, Stephanie E. Combs, Arjun Sahgal, Eric L. Chang, Simon S. Lo |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Expert review of anticancer therapy. 22(3) |
| ISSN: |
1744-8328 |
| Popis: |
Gestational trophoblastic diseases and neoplasias (GTDs and GTNs) comprise a spectrum of diseases arising from abnormally proliferating placental/trophoblastic tissue following an antecedent molar or non-molar pregnancy. These can spread to the brain hematogenously in about 10% of patients, mostly in high-risk disease. The optimal management of patients with brain metastases from GTN is unclear, with multiple systemic regimens under use and an uncertain role for radiotherapy.Here, we review the epidemiology, workup, and treatment of GTN with central nervous system (CNS) involvement. Literature searches in PubMed and Google Scholar were conducted using combinations of keywords such as 'gestational trophoblastic disease,' 'gestational trophoblastic neoplasia,' 'choriocarcinoma,' and 'brain metastases.'Systemic therapy is the frontline treatment for GTN with brain metastases, and radiotherapy should only be considered in the context of a clinical trial or for resistant/recurrent disease. Surgery has a limited role in palliating symptoms or relieving intracranial pressure/bleeding. Given the highly specialized care these patients require, treatment at a high-volume referral center with multidisciplinary collaboration likely leads to better outcomes. Randomized trials should be conducted to determine the best systemic therapy option for GTN. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
